SCHEMBL19361197

SCHEMBL19361197

O=C(Nc1ccccn1)N1c2nc(-c3ccccc3)ccc2N2CC[C@H]1C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.43
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNB4 P30926 1/20 0.41
▸ CHRNA3 P32297 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ NTRK1 P04629 2/20 0.39
▸ TRPV1 Q8NER1 1/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ NEK2 P51955 1/20 0.38
▸ IGF1R P08069 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD4 P21917 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ GRM5 P41594 1/20 0.37
▸ FGFR4 P22455 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ VCP P55072 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16238109 0.91 CNR2 (0.39) FAAHCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL19361196 0.90 TRPM8 (0.44) TRPV1
SCHEMBL17618388 0.90 VCP (0.43) FAAHNTRK1TRPV1MEN1KMT2A
SCHEMBL19699064 0.90 ABL1 (0.36) FAAHTRPV1MEN1KMT2AGRM5
SCHEMBL16775782 0.90 GRM5 (0.39) FAAHNTRK1RAB9ADRD2DRD4
SCHEMBL16238427 0.90 CNR2 (0.51) FAAHKMT2ARAB9AGRM5VCP
SCHEMBL17618561 0.90 CNR2 (0.41) FAAHTRPV1MEN1KMT2ARAB9A
SCHEMBL17618510 0.90 PIK3CA (0.41) FAAHNTRK1TRPV1MEN1KMT2A
SCHEMBL17618594 0.90 FAAH (0.43) FAAHNTRK1TRPV1MEN1KMT2A
SCHEMBL17618573 0.89 ATR (0.45) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10590135-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2020-03-17 — — US disclosed
US-9834558-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2017-12-05 — — US disclosed
US-9834558-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2017-12-05 — — US disclosed
US-9765075-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2017-09-19 — — US disclosed
US-9765075-B2 Substituted bridged urea analogs as sirtuin modulators GLAXOSMITHKLINE LLC (US) 2017-09-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10590135-B2 Substituted bridged urea analogs as sirtuin modulators SIRT1, SIRT3, SIRT2 FAAH 977/4885CHRNB2 4210/4885CHRNB4 4376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback